Cargando…

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer

INTRODUCTION: Although the survival rate of colorectal cancer (CRC) patients can be improved by surgery, radiotherapy, and chemotherapy, the resistance to 5-fluorouracil (5-Fu) affects the effect of chemotherapy and the prognosis of patients. An increasing number of studies showed that 5-Fu resistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yiping, Li, Kai, Zhang, Jieling, Wang, Lu, Sheng, Lili, Yan, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649235/ https://www.ncbi.nlm.nih.gov/pubmed/33177877 http://dx.doi.org/10.2147/CMAR.S255895

Ejemplares similares

miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1
por: Li, Kai, et al.
Publicado: (2021)

Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
por: Huang, Changhao, et al.
Publicado: (2020)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
por: Wu, Haili, et al.
Publicado: (2022)

Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p in vitro
por: Wang, Chen, et al.
Publicado: (2020)

The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine
por: Zhu, Yiping, et al.
Publicado: (2021)

The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
por: Mori, Ryutaro, et al.
Publicado: (2018)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells
por: Pu, Yiyi, et al.
Publicado: (2022)

Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT-8/5-Fu human colorectal cancer cell line
por: Zhang, Chao, et al.
Publicado: (2018)

Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
por: Zhang, Qian, et al.
Publicado: (2019)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling
por: Quan, Qiuying, et al.
Publicado: (2019)

PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis
por: Luo, Zhuhe, et al.
Publicado: (2022)

5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
por: Wang, Yongsheng, et al.
Publicado: (2010)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2022)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2023)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells
por: Wu, Mingcai, et al.
Publicado: (2020)

Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU
por: Sang, Jing, et al.
Publicado: (2020)

GALNT6 Knockdown Inhibits the Proliferation and Migration of Colorectal Cancer Cells and Increases the Sensitivity of Cancer Cells to 5-FU
por: Peng, Xiangdong, et al.
Publicado: (2021)

Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells
por: Zhu, Yuanyuan, et al.
Publicado: (2018)

FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression
por: Varghese, Vidhya, et al.
Publicado: (2019)

Predicting Agents That Can Overcome 5-FU Resistance in Colorectal Cancers via Pharmacogenomic Analysis
por: Huang, Tsui-Chin, et al.
Publicado: (2021)

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
por: Gmeiner, William H., et al.
Publicado: (2023)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer
por: Yang, Kai, et al.
Publicado: (2016)

Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients
por: Bensmaïne, M A, et al.
Publicado: (2001)

LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness
por: Zhu, Yihao, et al.
Publicado: (2020)

Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer
por: Hu, Hanqing, et al.
Publicado: (2018)

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
por: Rao, Shuyun, et al.
Publicado: (2019)

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer
por: Zhang, Guolin, et al.
Publicado: (2022)

Combined Therapeutic Effects of (131)I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
por: Wu, Pingping, et al.
Publicado: (2020)

GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death
por: Zhang, Zizhen, et al.
Publicado: (2021)

Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients
por: Fang, Ling, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9va4nsdeqc6orkh6m1o5bl6jpg